Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
2002 2
2003 2
2004 3
2005 5
2006 9
2007 24
2008 36
2009 99
2010 164
2011 298
2012 550
2013 643
2014 650
2015 663
2016 697
2017 733
2018 648
2019 551
2020 571
2021 549
2022 440
2023 343
2024 300
2025 248

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,279 results

Results by year

Filters applied: . Clear all
Page 1
[Dabigatran-induced oesophagitis].
Ykema BLM, van der Voorn MMPJA, Bhalla A. Ykema BLM, et al. Ned Tijdschr Geneeskd. 2019 Jun 26;163:D3228. Ned Tijdschr Geneeskd. 2019. PMID: 31276328 Dutch.
Dabigatran can have various gastro-intestinal side effects. In this article we describe the case of a patient with dabigatran-induced oesophagitis and we present an overview of current literature. ...CONCLUSION: It is important to recognize the symptoms and endoscop …
Dabigatran can have various gastro-intestinal side effects. In this article we describe the case of a patient with dabigatran- …
Dabigatran-induced esophagitis.
Kajihara Y. Kajihara Y. Cleve Clin J Med. 2019 May;86(5):303-304. doi: 10.3949/ccjm.86a.18117. Cleve Clin J Med. 2019. PMID: 31066667 Free article. No abstract available.
Idarucizumab: What Should We Know?
Cortese F, Calculli G, Gesualdo M, Cecere A, Zito A, De Vito F, Carbonara R, Carbonara S, Cortese AM, Ciccone MM. Cortese F, et al. Curr Drug Targets. 2018;19(1):81-88. doi: 10.2174/1389450118666170925155943. Curr Drug Targets. 2018. PMID: 28950812 Review.
BACKGROUND: Idarucizumab, a humanized monoclonal antibody fragment acting as a specific antidote for dabigatran, is approved for reversing the dabigatran-associated possible bleeding from critical sites or bleeding persisting despite local post-procedure haemostasis …
BACKGROUND: Idarucizumab, a humanized monoclonal antibody fragment acting as a specific antidote for dabigatran, is approved for reve …
Exfoliative esophagitis.
Kajihara Y. Kajihara Y. Eur J Intern Med. 2018 Jul;53:e1. doi: 10.1016/j.ejim.2017.12.013. Epub 2018 Jan 4. Eur J Intern Med. 2018. PMID: 29306680 No abstract available.
Ecarin based coagulation testing.
Gosselin RC, Douxfils J. Gosselin RC, et al. Am J Hematol. 2020 Jul;95(7):863-869. doi: 10.1002/ajh.25852. Epub 2020 May 30. Am J Hematol. 2020. PMID: 32350907 Free article. Review.
Ecarin based assays were rarely used for anticoagulation monitoring until the emergence of the direct oral thrombin inhibitor dabigatran etexilate in 2010. As this test was mentioned in the prescribing information for dabigatran etexilate, there was increased intere …
Ecarin based assays were rarely used for anticoagulation monitoring until the emergence of the direct oral thrombin inhibitor dabigatran …
Efficacy and safety of different oral anticoagulants for stroke prevention in older patients with atrial fibrillation: A network meta-analysis.
Zhang H, Liu F, Lu X. Zhang H, et al. Medicine (Baltimore). 2024 Oct 18;103(42):e39937. doi: 10.1097/MD.0000000000039937. Medicine (Baltimore). 2024. PMID: 39432641 Free PMC article.

Apixaban 5 mg, Dabigatran 110 mg, and Dabigatran 150 mg was more effective than the VKA for reducing stroke or systemic embolism risks, and the difference was statistically significant (P < .05). Apixaban 5 mg, Dabigatran 110 mg, Dabigatran 150 mg,

…
Apixaban 5 mg, Dabigatran 110 mg, and Dabigatran 150 mg was more effective than the VKA for reducing stroke or systemic emboli …
Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism.
Paik J. Paik J. Paediatr Drugs. 2022 Jul;24(4):423-431. doi: 10.1007/s40272-022-00516-z. Epub 2022 Jun 14. Paediatr Drugs. 2022. PMID: 35699915 Review.
Dabigatran etexilate was generally well tolerated; most bleeding events during treatment were minor. Although further data will be useful, dabigatran etexilate is a valuable and convenient treatment option in pediatric VTE....
Dabigatran etexilate was generally well tolerated; most bleeding events during treatment were minor. Although further data will be us …
Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review.
Thibault N, Morrill AM, Willett KC. Thibault N, et al. Am J Ther. 2018 May/Jun;25(3):e333-e338. doi: 10.1097/MJT.0000000000000460. Am J Ther. 2018. PMID: 27175894
BACKGROUND: The approval of the oral direct thrombin inhibitor, dabigatran etexilate, gave patients an alternative to oral anticoagulation with warfarin. Like all anticoagulants, the primary adverse event (AE) associated with dabigatran is bleeding. Until the FDA ap …
BACKGROUND: The approval of the oral direct thrombin inhibitor, dabigatran etexilate, gave patients an alternative to oral anticoagul …
7,279 results